New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cipher Pharmaceuticals Inc.
CPH.TO
Shape
US Flag

TSX

422M

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

422M

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

16.50CAD
Shape-0.04 ( -0.24%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-57%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

16%

Quote Panel

Shape
Updated October 22, 2024
1W -2.94 % 1M 11.56 % 3M 87.50 % 1Y 274.15 %

Key Metrics

Shape
  • Market Cap

    422.22M


  • Shares Outstanding

    25.59M


  • Share in Float

    14.40M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    16.5


  • Average Volume

    81622


  • Beta

    1.201


  • Range

    4.3-19.69


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.cipherpharma.com


  • Sector

    Healthcare


Fundamentals

Shape

13.06x

P/E Ratio

13.78x

P/S Ratio

3.24x

P/B Ratio

0.0

Debt/Equity

102.0%

Net Margin

$1.2

EPS

How CPH.TO compares to sector?

P/E Ratio

Relative Strength

Shape

CPH.TO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$50M

Shape846%

2025-Revenue

$0.67

Shape296%

2025-EPS

$29M

Shape700%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+100%

0.1
vs 0.05

Q4.22

arrow
arrow

+634%

0.77
vs 0.1

Q1.23

arrow
arrow

+22%

0.1
vs 0.08

Q2.23

arrow
arrow

+45%

0.12
vs 0.08

Q3.23

arrow
arrow

+170%

0.27
vs 0.1

Q4.23

arrow
arrow

-28%

0.56
vs 0.77

Q1.24

arrow
arrow

+173%

0.27
vs 0.1

Q2.24

arrow
arrow

+37%

0.16
vs 0.12

Q3.24

arrow
arrow

-27%

0.2
vs 0.27

Q4.24

arrow
arrow

-62%

0.21
vs 0.56

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+6%

4.8M  vs 4.5M

Q4.22

arrow
arrow

-16%

4.9M  vs 5.9M

Q1.23

arrow
arrow

-10%

4.9M  vs 5.4M

Q2.23

arrow
arrow

-5%

5.3M  vs 5.6M

Q3.23

arrow
arrow

+27%

6.1M  vs 4.8M

Q4.23

arrow
arrow

+0%

4.9M  vs 4.9M

Q1.24

arrow
arrow

+20%

5.9M  vs 4.9M

Q2.24

arrow
arrow

+0%

5.3M  vs 5.3M

Q3.24

arrow
arrow

+126%

13.7M  vs 6.1M

Q4.24

arrow
arrow

+226%

16.1M  vs 4.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+6%

0.06
vs 0.05

Q4.22

arrow
arrow

+31%

0.31
vs 0.06

Q1.23

arrow
arrow

+4%

0.04
vs 0.31

Q2.23

arrow
arrow

+4%

0.04
vs 0.04

Q3.23

arrow
arrow

+9%

0.09
vs 0.04

Q4.23

arrow
arrow

+10%

0.1
vs 0.09

Q1.24

arrow
arrow

+6%

0.06
vs 0.1

Q2.24

arrow
arrow

+3%

0.03
vs 0.06

Institutionnal OwnershipShape

status-upQoQ

Q3.15

arrow
arrow

21

21
vs 24

-12%

Q4.15

arrow
arrow

18

18
vs 21

-14%

Q1.16

arrow
arrow

16

16
vs 18

-11%

Q2.16

arrow
arrow

18

18
vs 16

13%

Q3.16

arrow
arrow

14

14
vs 18

-22%

Q4.16

arrow
arrow

2

2
vs 14

-86%

Q1.17

arrow
arrow

1

1
vs 2

-50%

Q2.17

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News